|

CUSTOMER SUPPORT »

Home

Products

Order

Technology

Company

Media

|

Web Site »

Home

Prove-it™ Herpes

Prove-it™ Sepsis

Prove-it™ Fungi

Prove-it™ Bone & Joint

Prove-it™ TubeArray System

Prove-it™ StripArray System

Support

Order

Local Distributors

Prove-it™ Biobank

Sample Preparation

Bacterial Identification

Antibacterial Resistance Markers

Viral Identification

Prove-it™ Advisor

Staff

Careers

Open Application

Contact

Meet Us

Quality

Media

News

Order Newsletter

Pictures for Media

Scientific Publications

Press Releases

This section presents Mobidiag's press releases in English. To read the press releases, please click the links below.

Apr 10, 2010
Prove-it™ News – the 20th ECCMID edition

Dec 10, 2009
As published in The Lancet: New DNA test for pathogenic bacteria is much faster than current Gold-standard system

Nov 11, 2009
Mobidiag Launches Rapid DNA Microarray Technology for Diagnostics of Bone and Joint Infections

Sep 09, 2009
Mobidiag Established New Distributor Agreement in Germany

Jul 02, 2009
Extensive and Rapid Diagnostic Assay for Herpesviral Infections in the Central Nervous System

May 18, 2009
Mobidiag Prove-it™ Herpes Achieves Excellent Results in Performance Evaluation

May 18, 2009
Mobidiag Launches Microchip Assay for Rapid Diagnostics of Bone and Joint Infections

May 18, 2009
Mobidiag Launches High Throughput Microarray Platform with Triple Assay Content Capacity

May 16, 2009
Mobidiag Extends Microbial Diagnostics Platform to Cover Bone and Joint Infections - Sets New World Record of Detecting 64 Dangerous Bacteria in a Single Test

Oct 30, 2008
Mobidiag Launches Life-Saving Diagnostic Test to Improve Sepsis Treatment in Hospitals

Apr 19, 2008
Finnish Biotech Company Sets World Record by Detecting 50 Dangerous Bacteria with Single Test in Quest to Battle Sepsis

Mar 12, 2008
Mobidiag Releases First Microarray Based Rapid Test for Herpesvirus Identification

© Copyright Mobidiag Ltd 2002-2010. All rights reserved. Terms and conditions | Privacy policy |
| +358-9-191 25021 | Biomedicum 2U, Tukholmankatu 8, FIN-00290 Helsinki, Finland